Announcing MedTech Actuator Origin Japan's semi-finalists
After three days of working closely with 13 medical startups in Japan, the MedTech Actuator is excited to announce four semi-finalists who will join the MedTech Actuator Origin in Australia next month.
MedTech Actuator Origin Japan kicked off its second cohort this week, welcoming a diverse range of medical and health innovations spanning diagnostic imaging, bioprinting, spinal implants, Autism Spectrum Disorder screening, and cancer treatments.
Emerging founders and entrepreneurs joined MedTech Actuator and partners JETRO, OCCI and OBDA for a 2-day bootcamp in Osaka, learning about pitching to a global market, commercialisation strategies and more.
Congratulations to AI4ASD, FairMed, Smile Curve and Spine Chronicle Japan
Judges and industry guests were blown away by the medical innovations and quality of each pitch. Congratulations to the selected semi-finalists:
AI4ASD | Aki Kono | An AI early screening tool for Autism Spectrum Disorder
FairMed | Sumire Fukuda | The development of AI to Assist Endovascular Surgery
Smile Curve | Masakatsu Noguchi | A new screening system with ICT to quantitatively measure body surface distortion
Spine Chronicle Japan | Ryo Kitagawa | Development of the best spinal implants for elderly patients
These Japanese startups will join MedTech Actuator in Melbourne next month for a week-long intensive program, where they will learn from industry experts, pressure test their innovations, and network with and pitch to Australia's startup ecosystem.
One Japanese startup will ultimately be selected to pitch at the MedTech Actuator Showcase on November 30 -- an industry event attended by 300 experts in BioMedical innovation -- competing for a cash and in-kind prize pack worth over $20,000.
MedTech Actuator Origin Japan is sponsored by JETRO and co-organized with JETRO, OCCI and OBDA.